Annual Gross Margin
-181.71%
NaN%
December 31, 2022
Summary
- As of February 21, 2025, NAVB annual gross profit margin is -181.71%
- During the last 3 years, NAVB annual gross margin has fallen by -256.66% (-342.44%).
- NAVB annual gross margin is now -281.91% below its all-time high of 99.89%, reached on December 31, 2015.
Performance
NAVB Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Margin
N/A
September 30, 2023
Summary
- NAVB quarterly gross profit margin is not available.
Performance
NAVB Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Gross Margin Formula
Gross Margin = Gross Profit
Revenue ✕ 100%
Revenue ✕ 100%
NAVB Gross Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -342.4% | - |
| 5 y5 years | -288.0% | - |
NAVB Gross Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | ||
| 5 y | 5-year | -283.3% | at low | ||
| alltime | all time | -281.9% | +96.9% |
Navidea Biopharmaceuticals Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -181.71%(-283.3%) | -8102.62%(+379.8%) |
| Sep 2022 | - | -1688.69%(-1920.9%) |
| Jun 2022 | - | 92.74%(-6.1%) |
| Dec 2020 | 99.12%(+32.2%) | - |
| Sep 2020 | - | 98.79%(+2.9%) |
| Jun 2020 | - | 96.00%(0.0%) |
| Mar 2020 | - | 96.00%(+0.0%) |
| Dec 2019 | 74.95%(+7.0%) | 95.97%(-0.1%) |
| Sep 2019 | - | 96.02%(-2.5%) |
| Jun 2019 | - | 98.50%(-204.3%) |
| Mar 2019 | - | -94.48%(-371.0%) |
| Dec 2018 | 70.04%(-27.5%) | 34.86%(-149.3%) |
| Sep 2018 | - | -70.76%(-181.7%) |
| Jun 2018 | - | 86.61%(+44.4%) |
| Mar 2018 | - | 60.00%(+0.0%) |
| Dec 2017 | 96.65%(-2.1%) | 59.99%(-41.6%) |
| Dec 2016 | 98.75%(-1.1%) | 102.71%(+2.9%) |
| Sep 2016 | - | 99.84%(-0.1%) |
| Jun 2016 | - | 99.93%(+0.1%) |
| Mar 2016 | - | 99.84%(+18.6%) |
| Dec 2015 | 99.89%(+33.7%) | 84.16%(-4.9%) |
| Sep 2015 | - | 88.50%(+0.1%) |
| Jun 2015 | - | 88.40%(+12.3%) |
| Mar 2015 | - | 78.70%(-8.2%) |
| Dec 2014 | 74.72%(+5.9%) | 85.69%(+33.7%) |
| Sep 2014 | - | 64.10%(-14.3%) |
| Jun 2014 | - | 74.83%(+0.7%) |
| Mar 2014 | - | 74.30%(+3.8%) |
| Dec 2013 | 70.56%(+5.2%) | 71.60%(-11.8%) |
| Sep 2013 | - | 81.16%(+76.4%) |
| Jun 2013 | - | 46.01%(-32.4%) |
| Jun 2010 | - | 68.03%(+1.7%) |
| Mar 2010 | - | 66.87%(-0.3%) |
| Dec 2009 | 67.07%(+7.3%) | 67.08%(+4.6%) |
| Sep 2009 | - | 64.15%(-5.8%) |
| Jun 2009 | - | 68.07%(-1.6%) |
| Mar 2009 | - | 69.19%(+4.0%) |
| Dec 2008 | 62.51%(+13.0%) | 66.54%(+8.2%) |
| Sep 2008 | - | 61.52%(+2.9%) |
| Jun 2008 | - | 59.79%(-5.1%) |
| Mar 2008 | - | 62.98%(+16.0%) |
| Dec 2007 | 55.30%(-2.1%) | 54.29%(-6.2%) |
| Sep 2007 | - | 57.86%(+7.4%) |
| Jun 2007 | - | 53.88%(-1.5%) |
| Mar 2007 | - | 54.71%(+4.4%) |
| Dec 2006 | 56.50% | 52.39%(-9.5%) |
| Sep 2006 | - | 57.91%(-0.3%) |
| Jun 2006 | - | 58.11%(-1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2006 | - | 58.77%(+6.8%) |
| Dec 2005 | 59.86%(-1.2%) | 55.04%(-8.4%) |
| Sep 2005 | - | 60.06%(-3.5%) |
| Jun 2005 | - | 62.24%(+1.1%) |
| Mar 2005 | - | 61.57%(+28.4%) |
| Dec 2004 | 60.61%(+16.6%) | 47.94%(-23.6%) |
| Sep 2004 | - | 62.71%(-6.6%) |
| Jun 2004 | - | 67.14%(+8.1%) |
| Mar 2004 | - | 62.11%(+33.3%) |
| Dec 2003 | 52.00%(-0.4%) | 46.58%(-19.7%) |
| Sep 2003 | - | 58.04%(-1.5%) |
| Jun 2003 | - | 58.95%(+29.6%) |
| Mar 2003 | - | 45.48%(-33.9%) |
| Dec 2002 | 52.22%(+12.5%) | 68.80%(+117.4%) |
| Sep 2002 | - | 31.64%(-28.4%) |
| Jun 2002 | - | 44.19%(-13.7%) |
| Mar 2002 | - | 51.18%(-10.7%) |
| Dec 2001 | 46.41%(-11.3%) | 57.32%(+33.2%) |
| Sep 2001 | - | 43.03%(+17.2%) |
| Jun 2001 | - | 36.71%(-11.4%) |
| Mar 2001 | - | 41.45%(-31.3%) |
| Dec 2000 | 52.31%(-10.0%) | 60.31%(+28.2%) |
| Sep 2000 | - | 47.06%(+0.7%) |
| Jun 2000 | - | 46.73%(-14.8%) |
| Mar 2000 | - | 54.87%(-13.1%) |
| Dec 1999 | 58.13%(-23.4%) | - |
| Jun 1999 | - | 63.16%(-7.7%) |
| Mar 1999 | - | 68.42%(-14.6%) |
| Dec 1998 | 75.93%(+9.6%) | 80.13%(+13.5%) |
| Sep 1998 | - | 70.59%(-8.2%) |
| Jun 1998 | - | 76.92%(-1.1%) |
| Mar 1998 | - | 77.78%(+20.3%) |
| Dec 1997 | 69.27%(+38.5%) | 64.64%(-16.0%) |
| Sep 1997 | - | 76.92%(-6.0%) |
| Jun 1997 | - | 81.82%(+50.0%) |
| Mar 1997 | - | 54.55%(+9.1%) |
| Sep 1996 | - | 50.00%(0.0%) |
| Jun 1996 | - | 50.00%(>+9900.0%) |
| Mar 1996 | - | 0.00%(-100.0%) |
| Dec 1995 | 50.00%(-43.8%) | 66.67%(>+9900.0%) |
| Sep 1995 | - | 0.00%(-100.0%) |
| Jun 1995 | - | 33.33%(0.0%) |
| Mar 1995 | - | 33.33%(-77.8%) |
| Dec 1994 | 88.89%(-101.5%) | 150.00%(+200.0%) |
| Sep 1994 | - | 50.00%(-107.7%) |
| Jun 1994 | - | -650.00%(-59.4%) |
| Mar 1994 | - | -1600.00% |
| Dec 1993 | -5800.00%(<-9900.0%) | - |
| Dec 1992 | 0.00% | - |
FAQ
- What is Navidea Biopharmaceuticals annual gross profit margin?
- What is the all time high annual gross margin for Navidea Biopharmaceuticals?
- What is the all time high quarterly gross margin for Navidea Biopharmaceuticals?
What is Navidea Biopharmaceuticals annual gross profit margin?
The current annual gross margin of NAVB is -181.71%
What is the all time high annual gross margin for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual gross profit margin is 99.89%
What is the all time high quarterly gross margin for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly gross profit margin is 150.00%